Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Lee D. Cranmer
Sign up to set email alerts
411
Publications
8,126
Citation Statements Received
6,084
Citation Statements Given
How they've been cited
10,624
247
7,853
26
How they cite others
7,496
172
5,890
22
Affiliations
University of Washington
,
Fred Hutch Cancer Center
Publications
Order By: Most citations
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
Andtbacka
1
,
Kaufman
2
,
Collichio
3
et al.
2015
JCO
Abstract
Show
2,720
34
2,262
4
Get access via publisher
Add to collection
Cite
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
Ribas
1
,
Puzanov
2
,
Dummer
3
et al.
2015
The Lancet Oncology
Abstract
Show
1,603
43
1,065
4
Get access via publisher
Add to collection
Cite
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial
Tap
1
,
Pápai
2
,
Van Tine
3
et al.
2017
The Lancet Oncology
Abstract
Show
319
6
252
0
2
Get access via publisher
Add to collection
Cite
T‐cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death‐ligand 1 expression in patients with soft tissue sarcomas
Pollack
1
,
He
2
,
Yearley
3
et al.
2017
Cancer
Abstract
Show
296
10
243
1
Get access via publisher
Add to collection
Cite
Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial
Andtbacka
1
,
Ross
2
,
Puzanov
3
et al.
2016
Ann Surg Oncol
Abstract
Show
317
10
239
2
Get access via publisher
Add to collection
Cite
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh
1
,
O'Day
2
,
Powderly
3
et al.
2010
Invest New Drugs
Abstract
Show
305
6
196
1
Get access via publisher
Add to collection
Cite
Final analysis of a randomised trial comparing pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory advanced melanoma
Hamid
1
,
Puzanov
2
,
Dummer
3
et al.
2017
European Journal of Cancer
190
16
174
0
Get access via publisher
Add to collection
Cite
nab
-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Wagner
1
,
Ravi
2
,
Riedel
3
et al.
2021
JCO
Abstract
Show
190
5
148
2
2
Get access via publisher
Add to collection
Cite
1
2
3